391 related articles for article (PubMed ID: 25468909)
21. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH
Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797
[TBL] [Abstract][Full Text] [Related]
22. Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion.
Gaudineau B; Fougère M; Guaddachi F; Lemoine F; de la Grange P; Jauliac S
J Cell Sci; 2012 Oct; 125(Pt 19):4475-86. PubMed ID: 22767506
[TBL] [Abstract][Full Text] [Related]
23. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice.
Guo H; Jin D; Zhang Y; Wright W; Bazuine M; Brockman DA; Bernlohr DA; Chen X
Diabetes; 2010 Jun; 59(6):1376-85. PubMed ID: 20332347
[TBL] [Abstract][Full Text] [Related]
24. The role of lipocalin-2 in liver regeneration.
Kienzl-Wagner K; Moschen AR; Geiger S; Bichler A; Aigner F; Brandacher G; Pratschke J; Tilg H
Liver Int; 2015 Apr; 35(4):1195-202. PubMed ID: 25040147
[TBL] [Abstract][Full Text] [Related]
25. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
26. Lipocalin-2 elicited by advanced glycation end-products promotes the migration of vascular smooth muscle cells.
Chung TW; Choi HJ; Kim CH; Jeong HS; Ha KT
Biochim Biophys Acta; 2013 Dec; 1833(12):3386-3395. PubMed ID: 24149112
[TBL] [Abstract][Full Text] [Related]
27. Lipocalin 2: a multifaceted modulator of human cancer.
Yang J; Moses MA
Cell Cycle; 2009 Aug; 8(15):2347-52. PubMed ID: 19571677
[TBL] [Abstract][Full Text] [Related]
28. Deamidated lipocalin-2 induces endothelial dysfunction and hypertension in dietary obese mice.
Song E; Fan P; Huang B; Deng HB; Cheung BM; Félétou M; Vilaine JP; Villeneuve N; Xu A; Vanhoutte PM; Wang Y
J Am Heart Assoc; 2014 Apr; 3(2):e000837. PubMed ID: 24721803
[TBL] [Abstract][Full Text] [Related]
29. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin.
Bachman MA; Miller VL; Weiser JN
PLoS Pathog; 2009 Oct; 5(10):e1000622. PubMed ID: 19834550
[TBL] [Abstract][Full Text] [Related]
30. Effect of NUCKS-1 overexpression on cytokine profiling in obese women with breast cancer.
Soliman NA; Zineldeen DH; El-Khadrawy OH
Asian Pac J Cancer Prev; 2014; 15(2):837-45. PubMed ID: 24568505
[TBL] [Abstract][Full Text] [Related]
31. Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease.
Oberoi R; Bogalle EP; Matthes LA; Schuett H; Koch AK; Grote K; Schieffer B; Schuett J; Luchtefeld M
PLoS One; 2015; 10(9):e0137924. PubMed ID: 26367277
[TBL] [Abstract][Full Text] [Related]
32. Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair.
Playford RJ; Belo A; Poulsom R; Fitzgerald AJ; Harris K; Pawluczyk I; Ryon J; Darby T; Nilsen-Hamilton M; Ghosh S; Marchbank T
Gastroenterology; 2006 Sep; 131(3):809-17. PubMed ID: 16952550
[TBL] [Abstract][Full Text] [Related]
33. Role of lipocalin-2 in brain injury after intracerebral hemorrhage.
Ni W; Zheng M; Xi G; Keep RF; Hua Y
J Cereb Blood Flow Metab; 2015 Sep; 35(9):1454-61. PubMed ID: 25853903
[TBL] [Abstract][Full Text] [Related]
34. NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene.
Fougère M; Gaudineau B; Barbier J; Guaddachi F; Feugeas JP; Auboeuf D; Jauliac S
Oncogene; 2010 Apr; 29(15):2292-301. PubMed ID: 20101218
[TBL] [Abstract][Full Text] [Related]
35. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner.
Mahadevan NR; Rodvold J; Almanza G; Pérez AF; Wheeler MC; Zanetti M
BMC Cancer; 2011 Jun; 11():229. PubMed ID: 21649922
[TBL] [Abstract][Full Text] [Related]
36. Lipocalin2 protects against airway inflammation and hyperresponsiveness in a murine model of allergic airway disease.
Dittrich AM; Krokowski M; Meyer HA; Quarcoo D; Avagyan A; Ahrens B; Kube SM; Witzenrath M; Loddenkemper C; Cowland JB; Hamelmann E
Clin Exp Allergy; 2010 Nov; 40(11):1689-700. PubMed ID: 20412141
[TBL] [Abstract][Full Text] [Related]
37. Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration.
Ip JP; Noçon AL; Hofer MJ; Lim SL; Müller M; Campbell IL
J Neuroinflammation; 2011 Sep; 8():124. PubMed ID: 21943033
[TBL] [Abstract][Full Text] [Related]
38. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity.
Law IK; Xu A; Lam KS; Berger T; Mak TW; Vanhoutte PM; Liu JT; Sweeney G; Zhou M; Yang B; Wang Y
Diabetes; 2010 Apr; 59(4):872-82. PubMed ID: 20068130
[TBL] [Abstract][Full Text] [Related]
39. Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions.
Labbus K; Henning M; Borkham-Kamphorst E; Geisler C; Berger T; Mak TW; Knüchel R; Meyer HE; Weiskirchen R; Henkel C
J Proteomics; 2013 Jan; 78():188-96. PubMed ID: 23219901
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanism underlying persistent induction of LCN2 by lipopolysaccharide in kidney fibroblasts.
Glaros T; Fu Y; Xing J; Li L
PLoS One; 2012; 7(4):e34633. PubMed ID: 22514649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
